Missing/wrong data?
Log in to edit
Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET)
scientific article (publication date: October 2003)
Author/s
author: David J Moliterno, Peter B. Berger, Gregg Stone, Peter M DiBattiste, Steven J Yakubov, Shelly K. Sapp, Kathy Wolski, Deepak L. Bhatt, Eric J. Topol
Work details
Publication date
October 1, 2003
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.